News
Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 8:00 AM ETCompany ParticipantsAlbert Bourla - Chairman of ...
20h
Zacks Investment Research on MSNPfizer Stock Down Almost 11% YTD: Should You Buy the Dip?Pfizer’s PFE stock has declined 10.7% so far this year compared with a decrease of 7.7% for the industry. The stock has also ...
21h
Zacks Investment Research on MSNPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should KnowPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but no ...
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...
Pfizer Inc. closed 26.70% short of its 52-week high of $31.54, which the company achieved on July 30th.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...
Berger Montague advises shareholders of Pfizer Inc. ("Pfizer" or the "Company") about an investigation into Pfizer's Board of Directors for potential breaches of fiduciary duties to Pfizer and its ...
German-based BioNTech , best known for its collaboration with Pfizer during the COVID-19 pandemic for developing vaccines, ...
PFE stock offers high dividend yields supported by cost optimizations and R&D. Discover its potential amid COVID-19 sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results